home / stock / acor / acor quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-01-26 | 7.53 | 7.45 | 7.69 | 7.35 | 387,307 |
2021-01-25 | 7.815 | 7.44 | 7.815 | 7.1 | 541,900 |
2021-01-22 | 7.28 | 7.6 | 7.65 | 7.15 | 523,386 |
2021-01-21 | 8.25 | 7.22 | 8.25 | 7.06 | 898,508 |
2021-01-20 | 8.02 | 8.04 | 8.66 | 7.62 | 1,279,399 |
2021-01-19 | 7.03 | 7.97 | 8.4 | 6.97 | 2,861,972 |
2021-01-18 | 6.24 | 6.7 | 6.72 | 6.0765 | 1,466,973 |
2021-01-15 | 6.24 | 6.7 | 6.72 | 6.0765 | 1,457,458 |
2021-01-14 | 6.1 | 6.37 | 6.66 | 5.776 | 2,273,573 |
2021-01-13 | 7.16 | 6.15 | 7.18 | 5.5 | 36,186,069 |
2021-01-12 | 4.11 | 4.24 | 4.27 | 4.1 | 312,145 |
2021-01-11 | 4.03 | 4.1 | 4.18 | 3.98 | 247,289 |
2021-01-08 | 4.18 | 4.11 | 4.18 | 3.99 | 327,315 |
2021-01-07 | 3.96 | 4.16 | 4.28 | 3.93 | 322,864 |
2021-01-06 | 4.07 | 3.905 | 4.28 | 3.89 | 434,133 |
2021-01-05 | 3.82 | 4.04 | 4.18 | 3.67 | 577,765 |
2021-01-04 | 3.57 | 3.8 | 3.83 | 3.37 | 868,528 |
2021-01-01 | 0.7232 | 0.6901 | 0.82 | 0.6839 | 12,642,283 |
2020-12-31 | 0.7232 | 0.6901 | 0.82 | 0.6839 | 12,572,810 |
2020-12-30 | 0.691 | 0.71 | 0.72 | 0.6757 | 2,118,242 |
Acorda Therapeutics Inc. Company Name:
ACOR Stock Symbol:
NASDAQ Market:
Acorda Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
$80 million up-front payment will substantially increase cash balance Sale, restructuring and other operating expense reductions will reduce annual operating expenses by approximately $40 million Total 2021 non-GAAP operating expense guidance expected to be $130-$140 million ...
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present at the 39 th Annual J.P. Morgan Health Care Conference on Thursday, January 14, at 5:20 PM ET. A live audio webcast of the presentation can be accessed under ...
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present during the January 11 th -14 th H.C. Wainwright BIOCONNECT Virtual Conference. An audio webcast of the presentation can be accessed under “Investor...